Suchergebnisse - Michael Method

Exposure–response relationships of mirvetuximab soravtansine in patients with folate receptor‐α‐positive ovarian cancer: Justification of therapeutic dose regimen Autoría: Ya‐Ping Tu, H. Maxime Lagraauw, Michael Method, Yuemei Wang, Eva Hanze, Lingling Li, Timothy Parrott, Callum M. Sloss, Eric H. Westin